Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb 12;26(4):1536.
doi: 10.3390/ijms26041536.

Autoimmune Pancreatitis Mimicking a Pancreatic Neuroendocrine Tumor: A Case Report with a Literature Review

Affiliations
Review

Autoimmune Pancreatitis Mimicking a Pancreatic Neuroendocrine Tumor: A Case Report with a Literature Review

Marianna Franchina et al. Int J Mol Sci. .

Abstract

Autoimmune pancreatitis (AIP) is a rare chronic pancreatitis subtype that often mimics pancreatic cancer due to the overlapping clinical and radiological features, posing significant diagnostic challenges. Similarly, distinguishing AIP from pancreatic neuroendocrine neoplasms (PanNENs), which present with nonspecific symptoms, adds complexity to clinical evaluations. We present the case of a 46-year-old male with recurrent acute idiopathic pancreatitis. Abdominal computed tomography (CT) revealed a 25 mm hypodense mass in the pancreatic tail with mild arterial contrast enhancement. Magnetic resonance imaging (MRI) showed the mass to be hypointense on T2-weighted sequences, with no diffusion restriction and an enhancement pattern akin to normal pancreatic tissue. The endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) was inconclusive. Gallium-68 DOTATATE positron emission tomography-CT (Ga-68 DOTATATE PET-CT) showed an increased tracer uptake, leading to a distal pancreatectomy with a splenectomy. Histopathology demonstrated chronic sclerotic pancreatitis with inflammatory infiltrates. Elevated serum IgG4 levels confirmed the diagnosis of type 1 AIP Differentiating AIP from pancreatic malignancies, including PanNENs, is both critical and complex. This case highlights a misdiagnosis of PanNENs in a patient with focal AIP, where neuroendocrine hyperplasia and islet cell clusters within fibrotic areas mimicked PanNENs, even on Ga-68 PET-CT. The findings emphasize the potential for false positives with Ga-68 DOTATATE PET-CT and the importance of integrating clinical, radiological, and histological data for an accurate diagnosis.

Keywords: autoimmune pancreatitis; chronic pancreatitis; pancreatic neuroendocrine tumors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
A CT scan performed with iodinated contrast media demonstrated a lesion in the distal pancreatic tail, measuring 23 mm × 18 mm (yellow arrow). The lesion appeared isodense to the surrounding pancreatic parenchyma across all contrast phases. It exhibited a compact glandular component with polylobulated margins. The spleen, liver, and surrounding retroperitoneal structures showed no abnormalities.
Figure 2
Figure 2
Increased tracer uptake in the pancreatic tail lesion was observed on Ga-68 DOTATATE PET-CT, suggestive of somatostatin receptor expression. The Ga-68 DOTATATE PET-CT was performed using an Omni Legend PET/CT scanner (GE HealthCare, Chicago, IL, USA).
Figure 3
Figure 3
A pseudonodular alteration was identified in the pancreatic tail, measuring approximately 25 mm. On T1-weighted post-contrast MRI sequences, the lesion appeared isointense relative to the surrounding pancreatic tissue, while on T2-weighted sequences, it was slightly hypointense (yellow arrows). The MRI was performed with a 1.5T magnet (Ingenia, Philips Healthcare, Amsterdam, The Netherlands). P = posterior.

Similar articles

References

    1. Shimosegawa T., Chari S.T., Frulloni L., Kamisawa T., Kawa S., Mino-Kenudson M., Kim M.H., Klöppel G., Lerch M.M., Löhr M., et al. International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352–358. doi: 10.1097/MPA.0b013e3182142fd2. - DOI - PubMed
    1. Masamune A., Kikuta K., Hamada S., Tsuji I., Takeyama Y., Shimosegawa T., Okazaki K. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J. Gastroenterol. 2020;55:462–470. doi: 10.1007/s00535-019-01658-7. - DOI - PubMed
    1. Löhr J.M., Beuers U., Vujasinovic M., Alvaro D., Frøkjær J.B., Buttgereit F., Capurso G., Culver E.L., de-Madaria E., Della-Torre E., et al. European Guideline on IgG4-related digestive disease—UEG and SGF evidence-based recommendations. United Eur. Gastroenterol. J. 2020;8:637–666. doi: 10.1177/2050640620934911. - DOI - PMC - PubMed
    1. Gallo C., Dispinzieri G., Zucchini N., Invernizzi P., Massironi S. Autoimmune pancreatitis: Cornerstones and future perspectives. World J. Gastroenterol. 2024;30:817–832. doi: 10.3748/wjg.v30.i8.817. - DOI - PMC - PubMed
    1. de Pretis N., Frulloni L. Autoimmune pancreatitis type 2. Curr. Opin. Gastroenterol. 2020;36:417–420. doi: 10.1097/MOG.0000000000000655. - DOI - PubMed

MeSH terms

LinkOut - more resources